litlas
Log inCreate account

John S. Macdonald

Active 1964–2012

52
Papers
27,426
Citations
50
h-index
52
i10-index

Citations

Citations per year for John S. Macdonald1959: 1 citations1971: 1 citations1973: 1 citations1976: 3 citations1977: 1 citations1978: 3 citations1979: 1 citations1980: 6 citations1981: 4 citations1982: 4 citations1983: 10 citations1984: 3 citations1985: 12 citations1986: 7 citations1987: 9 citations1988: 6 citations1989: 6 citations1990: 8 citations1991: 20 citations1992: 34 citations1993: 29 citations1994: 41 citations1995: 30 citations1996: 45 citations1997: 64 citations1998: 66 citations1999: 74 citations2000: 65 citations2001: 94 citations2002: 123 citations2003: 138 citations2004: 159 citations2005: 215 citations2006: 200 citations2007: 203 citations2008: 218 citations2009: 226 citations2010: 229 citations2011: 215 citations2012: 196 citations2013: 169 citations2014: 186 citations2015: 150 citations2016: 140 citations2017: 133 citations2018: 99 citations2019: 425 citations2020: 387 citations2021: 296 citations2022: 200 citations2023: 131 citations2024: 193 citations2025: 58 citations1960–1970: no citations, so these years are not shown1972: no citations, so this year is not shown1974–1975: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,107 citing papers, 31.5% of this breakdownChina: 516 citing papers, 7.7% of this breakdownUnited Kingdom: 416 citing papers, 6.2% of this breakdownGermany: 362 citing papers, 5.4% of this breakdownItaly: 312 citing papers, 4.7% of this breakdownCanada: 309 citing papers, 4.6% of this breakdownJapan: 303 citing papers, 4.5% of this breakdownFrance: 302 citing papers, 4.5% of this breakdownNetherlands: 288 citing papers, 4.3% of this breakdownSouth Korea: 158 citing papers, 2.4% of this breakdownAustralia: 157 citing papers, 2.3% of this breakdownSpain: 146 citing papers, 2.2% of this breakdown
0%31.5%Other 19.7%

Institutions

Fields

  • Medicine83.6%
  • Biochemistry, Genetics and Molecular Biology9.9%
  • Immunology and Microbiology0.9%
  • Physics and Astronomy0.8%
  • Computer Science0.7%
  • Social Sciences0.7%
  • Other3.4%

Topics

  • Colorectal Cancer Surgical Treatments6%
  • Gastric Cancer Management and Outcomes5.8%
  • Colorectal Cancer Treatments and Studies5%
  • Pancreatic and Hepatic Oncology Research4.4%
  • Brain Metastases and Treatment4.2%
  • Esophageal Cancer Research and Treatment3.9%
  • Other70.7%

Coauthors

All papers

Open in search
  1. ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer

    Authors: Gershon Y. Locker, Stanley R. Hamilton, Jules E. Harris, J. Milburn Jessup, Nancy E. Kemeny, John S. Macdonald, Mark R. Somerfield, Daniel F. Hayes, Robert C. Bast - Journal of Clinical Oncology 2006 cited by 1,584

  2. A Randomized Trial of Surgery in the Treatment of Single Metastases to the Brain

    Authors: Roy A. Patchell, Phillip A. Tibbs, John W. Walsh, Robert J. Dempsey, Yosh Maruyama, Richard J. Kryscio, William R. Markesbery, John S. Macdonald, Byron Young - New England Journal of Medicine 1990 cited by 3,152

  3. Chemoradiotherapy of Locally Advanced Esophageal Cancer

    Authors: Jay S. Cooper, Matthew Guo, Arnold Herskovic, John S. Macdonald, James A. Martenson, Muhyi Al‐Sarraf, Roger W. Byhardt, Anthony H. Russell, Jonathan J. Beitler, Sharon A. Spencer, Sucha O. Asbell, Mary V. Graham, Lawrence Leichman - JAMA 1999 cited by 1,966

  4. Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal Junction

    Authors: John S. Macdonald, Stephen R. Smalley, Jacqueline Benedetti, Scott A. Hundahl, Norman Estes, Grant N. Stemmermann, Daniel G. Haller, Jaffer A. Ajani, Leonard L. Gunderson, J. Milburn Jessup, James A. Martenson - New England Journal of Medicine 2001 cited by 3,509

  5. Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma

    Authors: Charles G. Moertel, Thomas R. Fleming, John S. Macdonald, Daniel G. Haller, John A. Laurie, Phyllis J. Goodman, James S. Ungerleider, William A. Emerson, Douglas C. Tormey, John H. Glick, Michael H. Veeder, James A. Mailliard - New England Journal of Medicine 1990 cited by 2,258

  6. Failure to Adhere to Protocol Specified Radiation Therapy Guidelines Was Associated With Decreased Survival in RTOG 9704—A Phase III Trial of Adjuvant Chemotherapy and Chemoradiotherapy for Patients With Resected Adenocarcinoma of the Pancreas

    Authors: Ross A. Abrams, Kathryn Winter, William F. Regine, Howard Safran, John P. Hoffman, Robert A. Lustig, André Konski, Al B. Benson, John S. Macdonald, Tyvin A. Rich, Christopher G. Willett - International Journal of Radiation Oncology*Biology*Physics 2011 cited by 276

  7. Colon Cancer Survival Is Associated With Decreasing Ratio of Metastatic to Examined Lymph Nodes

    Authors: Adam C. Berger, Elin R. Sigurdson, Thomas E. LeVoyer, Alexandra L. Hanlon, Robert J. Mayer, John S. Macdonald, Paul J. Catalano, Daniel G. Haller - Journal of Clinical Oncology 2005 cited by 517

  8. Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic Cancer

    Authors: James J. Farrell, Hany Elsaleh, M. López García, Raymond Lai, Ali Ammar, William F. Regine, Ross A. Abrams, Al B. Benson, John S. Macdonald, Carol E. Cass, Adam P. Dicker, John R. Mackey - Gastroenterology 2008 cited by 450

  9. Updated Analysis of SWOG-Directed Intergroup Study 0116: A Phase III Trial of Adjuvant Radiochemotherapy Versus Observation After Curative Gastric Cancer Resection

    Authors: Stephen R. Smalley, Jacqueline Benedetti, Daniel G. Haller, Scott A. Hundahl, Norman Estes, Jaffer A. Ajani, Leonard L. Gunderson, Bryan Goldman, James A. Martenson, J. Milburn Jessup, Grant N. Stemmermann, Charles D. Blanke, John S. Macdonald - Journal of Clinical Oncology 2012 cited by 857

  10. Fluorouracil vs Gemcitabine Chemotherapy Before and After Fluorouracil-Based Chemoradiation Following Resection of Pancreatic Adenocarcinoma

    Authors: William F. Regine, Kathryn Winter, Ross A. Abrams, Howard Safran, John P. Hoffman, André Konski, Al B. Benson, John S. Macdonald, Mahesh Kudrimoti, Mitchel Fromm, Michael G. Haddock, Paul Schaefer, Christopher G. Willett, Tyvin A. Rich - JAMA 2008 cited by 749

  11. Postresection CA 19-9 Predicts Overall Survival in Patients With Pancreatic Cancer Treated With Adjuvant Chemoradiation: A Prospective Validation by RTOG 9704

    Authors: Adam C. Berger, M. López García, John P. Hoffman, William F. Regine, Ross A. Abrams, Howard Safran, André Konski, Alan B. Benson, John S. Macdonald, Christopher G. Willett - Journal of Clinical Oncology 2008 cited by 367

  12. A Pooled Analysis of Adjuvant Chemotherapy for Resected Colon Cancer in Elderly Patients

    Authors: Daniel J. Sargent, Richard M. Goldberg, Stacy D. Jacobson, John S. Macdonald, Roberto Labianca, Daniel G. Haller, Lois E. Shepherd, Jean François Seitz, Guido Francini - New England Journal of Medicine 2001 cited by 994

  13. Fluorouracil-based Chemoradiation with Either Gemcitabine or Fluorouracil Chemotherapy after Resection of Pancreatic Adenocarcinoma: 5-Year Analysis of the U.S. Intergroup/RTOG 9704 Phase III Trial

    Authors: William F. Regine, Kathryn Winter, Ross A. Abrams, Howard Safran, John P. Hoffman, André Konski, Al B. Benson, John S. Macdonald, Tyvin A. Rich, Christopher G. Willett - Annals of Surgical Oncology 2011 cited by 307

  14. A phase II study of farnesyl transferase inhibitor R115777 in pancreatic cancer: A Southwest oncology group (SWOG 9924) study

    Authors: John S. Macdonald, Sheryl McCoy, Robert P. Whitehead, Syma Iqbal, James L. Wade, Jeffrey K. Giguere, James L. Abbruzzese - Investigational New Drugs 2005 cited by 151

  15. Differences in toxicity between men and women treated with 5‐fluorouracil therapy for colorectal carcinoma

    Authors: Kari Chansky, Jacqueline Benedetti, John S. Macdonald - Cancer 2005 cited by 150

  16. Impact of T and N Stage and Treatment on Survival and Relapse in Adjuvant Rectal Cancer

    Authors: Leonard L. Gunderson, Daniel J. Sargent, Joel E. Tepper, Norman Wolmark, Michael J. O’Connell, Mirsada Begovič, Cristine Allmer, Linda H. Colangelo, Steven R. Smalley, Daniel G. Haller, James A. Martenson, Robert J. Mayer, Tyvin A. Rich, Jaffer A. Ajani, John S. Macdonald, Christopher G. Willett, Richard M. Goldberg - Journal of Clinical Oncology 2004 cited by 436

  17. Impact of Body Mass Index on Outcomes and Treatment-Related Toxicity in Patients With Stage II and III Rectal Cancer: Findings From Intergroup Trial 0114

    Authors: Jeffrey A. Meyerhardt, Joel E. Tepper, Donna Niedzwiecki, Donna Hollis, Andrea M. McCollum, D. Brady, Michael J. O’Connell, Robert J. Mayer, Bernard Cummings, Christopher Willett, John S. Macdonald, Al B. Benson, Charles S. Fuchs - Journal of Clinical Oncology 2004 cited by 274

  18. Surveillance for Second Primary Colorectal Cancer after Adjuvant Chemotherapy: An Analysis of Intergroup 0089

    Authors: Robert J. Green, Joshua P. Metlay, Kathleen J. Propert, Paul J. Catalano, John S. Macdonald, Robert J. Mayer, Daniel G. Haller - Annals of Internal Medicine 2002 cited by 164

  19. Fluorouracil plus Levamisole as Effective Adjuvant Therapy after Resection of Stage III Colon Carcinoma: A Final Report

    Authors: Charles G. Moertel, Thomas R. Fleming, John S. Macdonald, Daniel G. Haller, John A. Laurie, Catherine M. Tangen, James S. Ungerleider, William A. Emerson, Douglass C. Tormey, John H. Glick, Michael H. Veeder, James A. Mailliard - Annals of Internal Medicine 1995 cited by 934

  20. Impact of Number of Nodes Retrieved on Outcome in Patients With Rectal Cancer

    Authors: Joel E. Tepper, Michael J. O’Connell, Donna Niedzwiecki, Donna Hollis, Carolyn C. Compton, Al B. Benson, Bernard Cummings, Leonard L. Gunderson, John S. Macdonald, Robert J. Mayer - Journal of Clinical Oncology 2001 cited by 569

  21. Influence of body mass index on outcomes and treatment‐related toxicity in patients with colon carcinoma

    Authors: Jeffrey A. Meyerhardt, Paul J. Catalano, Daniel G. Haller, Robert J. Mayer, Al B. Benson, John S. Macdonald, Charles S. Fuchs - Cancer 2003 cited by 309

  22. Phase III Study of Fluorouracil, Leucovorin, and Levamisole in High-Risk Stage II and III Colon Cancer: Final Report of Intergroup 0089

    Authors: Daniel G. Haller, Paul J. Catalano, John S. Macdonald, Mark Allen O’Rourke, Michael S. Frontiera, Don V. Jackson, Robert J. Mayer - Journal of Clinical Oncology 2005 cited by 393

  23. Combined-Modality Treatment for Resectable Metastatic Colorectal Carcinoma to the Liver: Surgical Resection of Hepatic Metastases in Combination With Continuous Infusion of Chemotherapy—An Intergroup Study

    Authors: M. Margaret Kemeny, Sudeshna Adak, Bruce N. Gray, John S. Macdonald, Thomas J. Smith, Stuart R. Lipsitz, Elin R. Sigurdson, Peter J. O’Dwyer, Al B. Benson - Journal of Clinical Oncology 2002 cited by 378

  24. Surgery for Recurrent Colon Cancer: Strategies for Identifying Resectable Recurrence and Success Rates after Resection

    Authors: Richard M. Goldberg, Thomas R. Fleming, Catherine M. Tangen, Charles G. Moertel, John S. Macdonald, Daniel G. Haller, John A. Laurie - Annals of Internal Medicine 1998 cited by 268